387 related articles for article (PubMed ID: 16520081)
1. Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors.
Arias HR; Bhumireddy P; Bouzat C
Int J Biochem Cell Biol; 2006; 38(8):1254-76. PubMed ID: 16520081
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
[TBL] [Abstract][Full Text] [Related]
3. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
Arias HR; Trudell JR; Bayer EZ; Hester B; McCardy EA; Blanton MP
Biochemistry; 2003 Jun; 42(24):7358-70. PubMed ID: 12809491
[TBL] [Abstract][Full Text] [Related]
4. Nicotinic receptors, allosteric proteins and medicine.
Changeux JP; Taly A
Trends Mol Med; 2008 Mar; 14(3):93-102. PubMed ID: 18262468
[TBL] [Abstract][Full Text] [Related]
5. Interaction of barbiturate analogs with the Torpedo californica nicotinic acetylcholine receptor ion channel.
Arias HR; McCardy EA; Gallagher MJ; Blanton MP
Mol Pharmacol; 2001 Sep; 60(3):497-506. PubMed ID: 11502880
[TBL] [Abstract][Full Text] [Related]
6. Molecular sites of general anaesthetic action on acetylcholine receptors.
Tonner PH; Miller KW
Eur J Anaesthesiol; 1995 Jan; 12(1):21-30. PubMed ID: 7535690
[TBL] [Abstract][Full Text] [Related]
7. Mechanism-based approach to the successful prevention of cocaine inhibition of the neuronal (alpha 3 beta 4) nicotinic acetylcholine receptor.
Krivoshein AV; Hess GP
Biochemistry; 2004 Jan; 43(2):481-9. PubMed ID: 14717603
[TBL] [Abstract][Full Text] [Related]
8. Allosterically linked noncompetitive antagonist binding sites in the resting nicotinic acetylcholine receptor ion channel.
Arias HR; McCardy EA; Bayer EZ; Gallagher MJ; Blanton MP
Arch Biochem Biophys; 2002 Jul; 403(1):121-31. PubMed ID: 12061809
[TBL] [Abstract][Full Text] [Related]
9. Tricyclic antidepressants inhibit homomeric Cys-loop receptors by acting at different conformational states.
Gumilar F; Bouzat C
Eur J Pharmacol; 2008 Apr; 584(1):30-9. PubMed ID: 18314100
[TBL] [Abstract][Full Text] [Related]
10. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors.
Tsetlin V; Utkin Y; Kasheverov I
Biochem Pharmacol; 2009 Oct; 78(7):720-31. PubMed ID: 19501053
[TBL] [Abstract][Full Text] [Related]
11. Probing the agonist domain of the nicotinic acetylcholine receptor by cysteine scanning mutagenesis reveals residues in proximity to the alpha-bungarotoxin binding site.
Spura A; Russin TS; Freedman ND; Grant M; McLaughlin JT; Hawrot E
Biochemistry; 1999 Apr; 38(16):4912-21. PubMed ID: 10213592
[TBL] [Abstract][Full Text] [Related]
12. [3H]Benzophenone photolabeling identifies state-dependent changes in nicotinic acetylcholine receptor structure.
Garcia G; Chiara DC; Nirthanan S; Hamouda AK; Stewart DS; Cohen JB
Biochemistry; 2007 Sep; 46(36):10296-307. PubMed ID: 17685589
[TBL] [Abstract][Full Text] [Related]
13. Positive and negative modulation of nicotinic receptors.
Arias HR
Adv Protein Chem Struct Biol; 2010; 80():153-203. PubMed ID: 21109220
[TBL] [Abstract][Full Text] [Related]
14. Mechanism-based discovery of small molecules that prevent noncompetitive inhibition by cocaine and MK-801 mediated by two different sites on the nicotinic acetylcholine receptor.
Chen Y; Banerjee A; Hess GP
Biochemistry; 2004 Aug; 43(31):10149-56. PubMed ID: 15287742
[TBL] [Abstract][Full Text] [Related]
15. Quinacrine noncompetitive inhibitor binding site localized on the Torpedo acetylcholine receptor in the open state.
Johnson DA; Ayres S
Biochemistry; 1996 May; 35(20):6330-6. PubMed ID: 8639577
[TBL] [Abstract][Full Text] [Related]
16. Mapping the structural requirements for nicotinic acetylcholine receptor activation by using tethered alkyltrimethylammonium agonists and antagonists.
Stewart DS; Chiara DC; Cohen JB
Biochemistry; 2006 Sep; 45(35):10641-53. PubMed ID: 16939216
[TBL] [Abstract][Full Text] [Related]
17. Channel inhibition by alkanols occurs at a binding site on the nicotinic acetylcholine receptor.
Wood SC; Tonner PH; de Armendi AJ; Bugge B; Miller KW
Mol Pharmacol; 1995 Jan; 47(1):121-30. PubMed ID: 7530805
[TBL] [Abstract][Full Text] [Related]
18. Site specificity of agonist-induced opening and desensitization of the Torpedo californica nicotinic acetylcholine receptor.
Andreeva IE; Nirthanan S; Cohen JB; Pedersen SE
Biochemistry; 2006 Jan; 45(1):195-204. PubMed ID: 16388595
[TBL] [Abstract][Full Text] [Related]
19. 2. Medicinal chemistry of alpha4beta2 nicotinic cholinergic receptor ligands.
Glennon RA
Prog Med Chem; 2004; 42():55-123. PubMed ID: 15003719
[No Abstract] [Full Text] [Related]
20. Use of calculated cation-pi binding energies to predict relative strengths of nicotinic acetylcholine receptor agonists.
Tantama M; Licht S
ACS Chem Biol; 2008 Nov; 3(11):693-702. PubMed ID: 19032090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
